ProShares Ultra Nasdaq Biotechnology (BIB)

During the Trading Day
91.84 +0.96 / +1.06%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
91.84 0.00 / 0.00%
Volume: 850.00

Investment Objective

The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index ®. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified.


1 month+3.45% 3 years+87.34%
3 months+17.38% 5 years+78.04%
1 year+84.37% Since inception+61.04%
Data through 07/03/2015

Quote Details

Previous close$90.88
Open day’s range88.72 – 93.56
Net asset value (NAV)90.82 (07/02/2015)
Daily volume694,178
Average volume (3 months)866,967
Data as of 3:59pm ET, 07/06/2015

Peer Comparisonvs. Trading-leveraged equity ETFs

Performance 5-yr return+78.04%+21.46%
Expense Gross exp ratio1.08%0.89%
Risk 5 year sharpe ratio1.81--
Net assets$902.6M$169.3M
Average market cap----
Average P/E----
Dividend / Share--0.20%


SFLA iPath® Long Extended S&P 500® TR Index...
SSO ProShares Ultra S&P500
ROLA iPath® Long Extended Russell 1000® TR ...


Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
-- 60.69%
-- 17.41%
-- 17.38%
-- 9.25%
-- 7.98%
BIIB Biogen5.67%
AMGN Amgen5.58%
CELG Celgene5.22%
GILD Gilead Sciences5.21%
-- 4.62%

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers